Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005003 · ClinicalTrials.gov registry record

Genetic Component of Handedness

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
1,400
Enrollment target

NCT00005003: Completed study, sponsored by National Cancer Institute (NCI).

NCT00005003 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00005003 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
1,400 participants
Enrollment target

Study Summary

Some functions are generally controlled by the right side of the brain and others by the left. One of the most easily observed examples of this "lateral specialization" of the brain is handedness-that is, a person's preference for using either the right or the left hand. This study will try to determine how the genetic component of handedness is inherited. It will test the theory that a single gene is involved in determining handedness and will try to locate the gene. Families with at least two left-handed siblings aged eight years or older and at least one right-handed parent are eligible to participate in this study. The left-handed siblings and both parents will fill out a brief questionnaire on hand usage, obtain a tissue sample taken from inside the cheek, and return the questionnaire and the sample by mail to the study researchers. The tissue sample will be used for DNA gene mapping. Participants will be given a kit and instructions for obtaining the sample, along with mailing envelopes. Cheek swab sampling basically involves using a small brush to gently brush a layer of cells off of the inner wall of the cheek and then dropping the brush tip into a preservative. The information gained from this study may provide insight into aspects of brain development that can be of medical benefit in the future.

Trial Details

FieldValue
Enrollment Target 1,400 participants
Start Date 2000-03
Est. Completion 2006-04
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00005003 record still lists

NCT00005003 is an observational study that tracks outcomes without assigning an intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00005003 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00005003 about?

NCT00005003 is a clinical study titled "Genetic Component of Handedness". Some functions are generally controlled by the right side of the brain and others by the left. One of the most easily observed examples of this "lateral specialization" of the brain is handedness-that is, a person's preference for using either the right or the left hand. This study will try to deter...

What is the current status of trial NCT00005003?

This trial is currently completed. The enrollment target is 1,400 participants. The study started on 2000-03. Estimated completion is 2006-04.

Who is sponsoring clinical trial NCT00005003?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02205762 · 1,400 participants · Phase 2

    LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

  • NCT02445222 · 1,400 participants · Phase 3

    CAR-T Long Term Follow Up (LTFU) Study

  • NCT03145077 · 1,400 participants · NA

    Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

  • NCT04250857 · 1,400 participants

    HeartStart FRx Defibrillator Event Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005003, the US trial registry maintained by the National Library of Medicine. NCT00005003 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.